Targeted Navigation in Hepatocellular Carcinoma (HCC)
NCT06260943 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100
Last updated 2025-07-15
Summary
The investigators are trying to learn more about the personal perceptions and experiences regarding the needs of patients with liver cancer to help improve the care of all patients. The investigators would like to know whether there are needs that patients have or are aware of, especially those needs that the investigators have not been able to address. The investigators aim to develop a program that helps participants and participant's families to navigate the process of being diagnosed with liver cancer and receiving treatment.
Conditions
- Hepatocellular Carcinoma
- Cholangiocarcinoma
- Hepatobiliary Cancer
Interventions
- BEHAVIORAL
-
Target Navigation Pilot Program
Participants will meet with a navigator, in either English, Spanish or Creole, biweekly, in person or virtually, until the first treatment appointment and every three months after. Each session will last approximately one hour; depending on the needs identified, patients will be connected to appropriate institutional or community-based resources.
Sponsors & Collaborators
-
The V Foundation
collaborator OTHER -
University of Miami
lead OTHER
Principal Investigators
-
Patricia Jones, MD · University of Miami
Study Design
- Allocation
- NA
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2024-04-15
- Primary Completion
- 2026-10-31
- Completion
- 2026-10-31
Countries
- United States
Study Locations
More Related Trials
-
Adjuvant Therapies for Patients With HCC and MVI
NCT02436902 ·Status: UNKNOWN ·Phase: PHASE3
-
Neoadjuvant Therapy of HAIC(GEMOX) Combined With Adebrelimab and Lenvatinib for Resectable Intrahepatic Cholangiocarcinoma With High-risk Recurrence Factors
NCT06208462 ·Status: RECRUITING ·Phase: PHASE2
-
Liver Cancer Community Education
NCT04272619 ·Status: COMPLETED ·Phase: NA
-
The Detection of Circulating Tumor Cells (CTCs) in Patients With Liver Cancer Undergoing Cryosurgery Combined With DC-CIK Treatment
NCT02416635 ·Status: COMPLETED
-
HCC Patient Preferences in Japan
NCT02616692 ·Status: COMPLETED
-
STOP HCC: Mailed HCV Treatment Outreach Program for HCC Prevention
NCT03706742 ·Status: COMPLETED ·Phase: NA
-
Clinical Study on the Effectiveness and Safety of Lenvatinib As Adjuvant Treatment for Patients with High-risk Recurrence of Hepatocellular Carcinoma After Surgery
NCT06762782 ·Status: RECRUITING ·Phase: PHASE2
-
A Social Support Intervention to Improve Treatment Among Hispanic Kidney and Liver Cancer Patients in Arizona
NCT05418387 ·Status: WITHDRAWN ·Phase: NA
-
Comprehensive Electronic Cancer Support System for the Treatment of Cancer Related Symptoms
NCT01640522 ·Status: COMPLETED ·Phase: NA
-
Artificial Intelligence and Hepatocellular Carcinoma
NCT05637788 ·Status: ACTIVE_NOT_RECRUITING
-
Liver Cancer Registry Platform
NCT04510740 ·Status: RECRUITING
-
Systemic Chemotherapy Versus Transcatheter Arterial Chemoembolization(TACE) for Hepatocellular Carcinoma
NCT02585479 ·Status: WITHDRAWN ·Phase: PHASE2/PHASE3
-
Hepatic Arterial Infusion in Treating Patients With Locally Advanced, Non-Metastatic Cholangiocarcinoma
NCT01525069 ·Status: TERMINATED ·Phase: PHASE1
-
HAI or IV of Adebrelimab, Combined With Bevacizumab and HAI of FOLFOX for Advanced Unresectable Hepatocellular Carcinoma
NCT06737913 ·Status: RECRUITING ·Phase: PHASE2
-
Efficacy of Target - Immunotherapy and XELOX Chemotherapy for Advanced HCC
NCT06818097 ·Status: COMPLETED
-
Recurrent Liver Cancer: Reconceptualization and Reevaluation
NCT06430983 ·Status: RECRUITING
-
HAIC Combined with PD-1 Inhibitor in Potentially Resectable Locally Advanced HCC
NCT03869034 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
HAIC Versus Systemic Chemotherapy for Unresectable ICC
NCT03771846 ·Status: UNKNOWN ·Phase: PHASE3
-
Trajectory-Based Prognostic Modeling in Hepatocellular Carcinoma
NCT07204262 ·Status: COMPLETED
-
Bioinformation Therapy for Liver Cancer
NCT03239158 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Trial of Behavioral Intervention on Prognostic Survival of Patients With Unresectable Liver Cancer
NCT07337031 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
HAIC Plus PD-1 Antibody vs HAIC Plus Sorafenib for Advanced HCC
NCT03780634 ·Status: WITHDRAWN ·Phase: PHASE2
-
HAIC Plus Systemic Chemotherapy, Lenvatinib and Toripalimab in Advanced ICC
NCT07304388 ·Status: COMPLETED ·Phase: PHASE2
-
HAIC Plus Targeted Therapy and/or PD-1 Inhibitors for Unresectable Intrahepatic Cholangiocarcinoma
NCT05489692 ·Status: COMPLETED
-
Perception of the Doctor/Patient Relationship, Disease and Treatment Among Physicians and Their Patients Treated With Systemic Therapy for Hepatocellular Carcinoma "PERCEPTION1"
NCT04823754 ·Status: COMPLETED